The IPRO goal was to design a process for the production of the biotherapeutic compound IFN-Alpha from Chinese Hamster ovaries. After the process design was complete, a process flow diagram showing the actual process and separation steps was created and finally an economic analysis of the market feasibility of the product was prepared. The approach to the IPRO involved dividing the objectives into three major groups: (1) the Che 496 group was involved in the process design and the separation processes; (2) the Che 296 group was involved in the public perception of biotechnology, the useful products from biotechnology and the survey of the commercial biotherapeutic compounds; and (3) the 435 group was involved with the history of biotherapeutics, classification and actions infernos and the companies involved in the production of therapeutics. The individual members of these groups are seen on the team list below.Deliverables for IPRO 345: Design Project for Production of IFN-alpha for the Spring 2006 semeste
